MUSTAFA ALADIN: Open Payments
NPI 1538546791 · WESTMONT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 32 payments from 11 companies in 2025. Trend: 2023 $374 · 2024 $412 · 2025 $534
Food & beverage: $518Education: $16
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 11 | $150 |
| Novo Nordisk Inc | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| PFIZER INC. | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
Products named: ZORYVE, Ozempic, CAPLYTA, REXULTI, BREZTRI, Wegovy, PREVNAR 20, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
